Intermittent Theta Burst to the Left Dorsolateral Prefrontal Cortex as an Adjunctive Treatment for Alcohol Use Disorder
Information
Date & Time
-
-
Brought to you by
Learning Objectives
Participants will be able to:
-
Describe the fundamental physics of transcranial magnetic stimulation (TMS).
-
Identify at least two psychiatric or biomedical conditions where TMS is an approved treatment by the FDA.
-
Describe primary differential clinical outcomes for active vs. sham in the random clinical trial presented.
Educational Goal
The educational goal of this workshop is to increase knowledge about TMS and iTBS.
Description
Over 60% of individuals with alcohol use disorder (AUD) resume hazardous consumption levels within 6 months post-treatment, necessitating development of more efficacious interventions. Accumulating evidence suggests transcranial magnetic stimulation (TMS) is a promising intervention for AUD. This presentation will cover basic TMS physics, TMS application to other psychiatric and biomedical conditions, and present data from a randomized, double-blind, placebo-controlled trial assessing the efficacy of intermittent theta burst (iTBS), a form of TMS, as an adjunct treatment for Armed Services Veterans with AUD.
Target Audience
- Counselor
- Marriage & Family Therapist
- Psychologist
- Social Worker
- Substance Use Disorder Professionals
Presenters
Timothy C. Durazzo, PhD is a Clinical Neuropsychologist at the VA Palo Alto Heath Care System Mental Illness Research Education Clinical and Professor in Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. He is an Army Veteran and currently serves as the Commanding Officer of the 297th Medical Company Area Support of the CA Army National Guard. His clinical work focuses on the neuropsychological assessment of those with alcohol and substance use disorders and neurodegenerative diseases. A primary focus of Dr. Durazzo’s research program in on the effects of cigarette smoking on the neurobiological and neurocognitive recovery from alcohol and substance use disorders, and traumatic brain injury, as well as the association of cigarette smoking with risk of Alzheimer’s disease-related neuropathology and abnormal aging. His research program also conducts randomized clinical trials evaluating the efficacy of repetitive transcranial magnetic stimulation for the treatment of alcohol use disorder.